Literature DB >> 20095980

Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis.

L E Almaguer-Mederos1, N S Falcón, Y R Almira, Y G Zaldivar, D C Almarales, E M Góngora, M P Herrera, K E Batallán, R R Armiñán, M V Manresa, G S Cruz, J Laffita-Mesa, T M Cyuz, V Chang, G Auburger, S Gispert, L V Pérez.   

Abstract

Previous studies have investigated the close association that exists between CAG repeat number and the age at onset in SCA2 = spinocerebellar ataxia type 2. These studies have focused on affected individuals. To further characterize this association and estimate the risk of a carrier developing SCA2 at a particular age as a function of a specific CAG repeat size, we have analyzed a large group of 924 individuals, including 394 presymptomatic and 530 affected individuals with a CAG repeat length of 32-79 units. Using a Kaplan-Meier survival analysis, we obtained cumulative probability curves for disease manifestation at a particular age for each CAG repeat length in the 34-45 range. These curves were significantly different (p < 0.001) and showed small overlap. All these information may be very valuable in predictive-testing programs, in the planning of studies for the identification of other genetic and environmental factors as modifiers of age at onset, and in the design of clinical trials for people at enlarged risk for SCA2.

Entities:  

Mesh:

Year:  2009        PMID: 20095980     DOI: 10.1111/j.1399-0004.2009.01358.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

1.  Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.

Authors:  José Miguel Laffita-Mesa; Peter O Bauer; Vivian Kourí; Leodani Peña Serrano; Jane Roskams; Dennis Almaguer Gotay; Julio Cesar Montes Brown; Pedro Ariel Martínez Rodríguez; Yanetza González-Zaldívar; Luís Almaguer Mederos; Dany Cuello-Almarales; Jorge Aguiar Santiago
Journal:  Hum Genet       Date:  2011-10-30       Impact factor: 4.132

2.  Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Edilia M Cruz-Rivas; Juan Fernández-Ruiz; Israel Vaca-Palomares; Jandy Lilia-Campins; Bulmaro Cisneros; Arnoy Peña-Acosta; Yaimeé Vázquez-Mojena; Rosalinda Diaz; Jonathan J Magaña-Aguirre; Tania Cruz-Mariño; Annelié Estupiñán-Rodríguez; José M Laffita-Mesa; Rigoberto González-Piña; Nalia Canales-Ochoa; Yanetza González-Zaldivar
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

Review 3.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

Review 4.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

5.  Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.

Authors:  Annalese G Neuenschwander; Khanh K Thai; Karla P Figueroa; Stefan M Pulst
Journal:  JAMA Neurol       Date:  2014-12       Impact factor: 18.302

6.  Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2.

Authors:  Almaguer-Gotay Dennis; Luis E Almaguer-Mederos; Rodríguez-Aguilera Raúl; Rodríguez-Labrada Roberto; Velázquez-Pérez Luis; Cuello-Almarales Dany; González-Zaldívar Yanetza; Vázquez-Mojena Yaimeé; Estupiñán-Domínguez Annelié; Peña-Acosta Arnoy; Torres-Vega Reydenis
Journal:  Oxid Med Cell Longev       Date:  2021-02-19       Impact factor: 6.543

7.  Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.

Authors:  Sophie Tezenas du Montcel; Alexandra Durr; Maria Rakowicz; Lorenzo Nanetti; Perrine Charles; Anna Sulek; Caterina Mariotti; Rafal Rola; Ludger Schols; Peter Bauer; Isabelle Dufaure-Garé; Heike Jacobi; Sylvie Forlani; Tanja Schmitz-Hübsch; Alessandro Filla; Dagmar Timmann; Bart P van de Warrenburg; Cecila Marelli; Jun-Suk Kang; Paola Giunti; Arron Cook; Laszlo Baliko; Béla Melegh; Melegh Bela; Sylvia Boesch; Sandra Szymanski; José Berciano; Jon Infante; Katrin Buerk; Marcella Masciullo; Roberto Di Fabio; Chantal Depondt; Susanne Ratka; Giovanni Stevanin; Thomas Klockgether; Alexis Brice; Jean-Louis Golmard
Journal:  J Med Genet       Date:  2014-04-29       Impact factor: 6.318

8.  Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.

Authors:  Kathrin Reetz; Roberto Rodríguez-Labrada; Imis Dogan; Shahram Mirzazade; Sandro Romanzetti; Jörg B Schulz; Edilia M Cruz-Rivas; Jose A Alvarez-Cuesta; Raul Aguilera Rodríguez; Yanetza Gonzalez Zaldivar; Georg Auburger; Luis Velázquez-Pérez
Journal:  Ann Clin Transl Neurol       Date:  2018-01-07       Impact factor: 4.511

9.  Spinocerebellar ataxia 2 in a family with different phenotypes: Two case reports.

Authors:  Yuanyuan Li; Ying Chang; Xiufeng Liu; Yanyan Li; Yayun Yan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

10.  The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.

Authors:  Thais Lampert Monte; Estela da Rosa Reckziegel; Marina Coutinho Augustin; Lucas D Locks-Coelho; Amanda Senna P Santos; Gabriel Vasata Furtado; Eduardo Preusser de Mattos; José Luiz Pedroso; Orlando Póvoas Barsottini; Fernando Regla Vargas; Maria-Luiza Saraiva-Pereira; Suzi Alves Camey; Vanessa Bielefeldt Leotti; Laura Bannach Jardim
Journal:  Orphanet J Rare Dis       Date:  2018-01-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.